Adma Biologics

ADMANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$2.197 B

$9.81 +3.21%

Close of 22 Sept 2026

Revenue

$510.2M

#1893 by revenue

Earnings

$146.9M

#1142 by earnings

Shares outstanding

223,984,680

Latest filing cover page

P/E ratio

15.0

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#29AlvotechALVO$2.28B
#30Biocryst PharmaceuticalsBCRX$2.24B
#31Adma BiologicsADMA$2.20B
#32Recursion PharmaceuticalsRXRX$2.17B
#33Kodiak SciencesKOD$2.12B

What if Adma Biologics were worth as much as…

Open the what-if tool →

Gold $30.2T

$134,982.31

Per share 13,760× higher

Bitcoin $1.74T

$7,775.78

Per share 793× higher

Nvidia $5.52T

$24,625.64

Per share 2,510× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Adma Biologics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.